Mission Therapeutics of the UK has struck a deal to out-license a drug for acute kidney injury to Australia's Dimerix, ...

Three years after buying Bellus Health and its chronic cough candidate camlipixant for around $2 billion, GSK is abandoning ...

In the biggest venture capital financing this week, clinical-stage radiopharmaceutical AdvanCell has closed a $315 million ...

All 15-year-old children in the UK should be offered the vaccine against meningitis B (MenB) in the wake of fatal outbreaks ...

For decades, pharmaceutical marketing has been built on a simple premise: if we present the right data, to the right audience ...

Reports are emerging that a multibillion-dollar partnership between AbbVie and Alphabet-backed biotech Calico has come to an end after more than a decade. The divorce – first report by Stat – comes ...

Though they are still primarily prescribed for weight loss and diabetes, researchers are looking at the effects of GLP-1s for a wide variety of conditions from substance abuse dis ...

In the first big announcement from this year's JPM Healthcare conference, AbbVie has joined the ranks of companies developing cancer drugs that target both PD-1 and VEGF – one of the hottest drug ...

Basecamp Research has launched a new scientific initiative, called the Trillion Gene Atlas, to bring together genomic data from millions of species and use it to guide and scale AI-powered design of ...

Eli Lilly has stepped up its campaign to encourage people to use its weight-loss drug Zepbound over copycat drugs from other sources, such as compounding pharmacies. The drugmaker used a 30-second ...

In this Q&A, Paolo Correale, SVP of global access and pricing at EVERSANA, and Alan Crowther, general manager, global pricing ...

MSD has won the race to bring an oral PCSK9 inhibitor through to regulatory approval in the US, after getting the go-ahead ...